Category Archives: Drugs

The government's war on drugs has been hailed as a remarkable success thanks to a significant increase in drug gangs busted, drugs seized, and drug addicts rehabilitated. Somchai: Govt on the right track And the key to success, the Royal Thai Police and the Office of the Narcotics Control Board (ONCB) say, is the government's clear policy which has made it easier for law enforcement authorities to take action. Deputy National Police Chief Pol Gen Adul Saengsingkaew said he was satisfied with the outcome of the anti-drugs policy implementation in the past year, given the increased the number of drug suspects arrested and addicts rehabilitated. "Regarding these statistics, the war on drugs now is going much better than it was under the previous government. Actually, it is even better than under the Thaksin Shinawatra administration which initiated this policy in 2001," said Pol Gen Adul, who also serves as acting secretary-general of the ONCB. Since Sept 11 last year, when the Yingluck Shinawatra government kicked off its version of the war on drugs, about 340,000 drug cases have been prosecuted, nearly 8% more than in the same period the year before. More than 330,000 suspects have been arrested, a 14% … Continue reading →

NEW YORK, Aug. 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: http://www.reportlinker.com/p0945797/Commercializing-Breast-Cancer-Drugs-The-Faster-Route-to-Consider-Your-Options-and-Position-of-Others.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report will excel your competitive awareness and decrease your decision making time in managing breast cancer drug development. Find out whether you are number one, two or further down the ladder in this highly competitive market. Locate the right drugs to benchmark against and see were others may have succeeded or failed before you. This report comprises defined and up to date development strategies for 470 breast cancer drugs within the portfolio of 247 companies world-wide, from Ceased to Marketed. The report extensively analyses their 234 identified drug targets, organized into 223 drug target strategies, and assesses them in breast cancer. BioSeeker has applied its unique drug assessment methodology to stratify the breast cancer drug pipeline and discern the level of competition in fine detail. * The identified competitive landscape of breast cancer drugs is split between the approximately one third which have unique drug target strategies and the other two thirds which have head-to-head target competing drugs in 61 different clusters. The latter has a competing ratio which is almost two and a half times higher than … Continue reading →

Aug. 16, 2012, midnight DRUGS will ruin your life that was the message Shepparton magistrate John Murphy yesterday gave a man charged with attempted armed robbery. Adam Rhyce Tempo, 32, of Cobram, had told Mr Murphy he had no recollection of allegedly trying to rob a Cobram service station on Monday night, armed with a knife and making threats to kill. He had said alcohol, mixed with prescription anxiety medication Xanax seems to black me right out. Detective Sergeant Marcus Boyd told Shepparton Magistrates Court an armed, balaclava-clad man entered the Caltex station on the Murray Valley Highway about 6.55pm and demanded money. But the attendant took a baseball bat from below the counter and whacked Mr Tempo a couple of times before he left. Det Sgt Boyd said television footage showed the man was wearing a very bright pair of blue shoes and a distinctive balaclava. Police found Mr Tempo later that evening in a very drug-induced state with several unexplained injuries. Police had found a balaclava at Tempos house. Tempo told Mr Murphy his life was falling apart. This behaviour definitely isnt me, he said. More: Drugs wrecking you, bungling bandit told … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/8ksjxz/commercializing_br) has announced the addition of the "Commercializing Breast Cancer Drugs: The Faster Route to Consider Your Options and Position of Others" report to their offering. This report will excel your competitive awareness and decrease your decision making time in managing breast cancer drug development. Find out whether you are number one, two or further down the ladder in this highly competitive market. Locate the right drugs to benchmark against and see were others may have succeeded or failed before you. This report comprises defined and up to date development strategies for 470 breast cancer drugs within the portfolio of 247 companies world-wide, from Ceased to Marketed. The report extensively analyses their 234 identified drug targets, organized into 223 drug target strategies, and assesses them in breast cancer. BioSeeker has applied its unique drug assessment methodology to stratify the breast cancer drug pipeline and discern the level of competition in fine detail. Major Findings from this report: - The identified competitive landscape of breast cancer drugs is split between the approximately one third which have unique drug target strategies and the other two thirds which have head-to-head target competing drugs in 61 different clusters. The … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/kczh7m/generic_and_innova) has announced the addition of the "Generic And Innovative Drugs Market In Poland 2012" report to their offering. Generic and innovative drugs market in Poland 2012, Development forecasts for 2012-2014 is a comprehensive source of data and analysis focused on recent and impending changes in the market resulting from the January 2012 reimbursement act. This legislation has the power to change the framework of the Polish pharmaceutical sector, particularly the generic and innovative drug segments, and the report guides readers to a thorough understanding of the act's provisions and offers ways for companies to adapt to the new rules and preserve their profits. In addition to providing complete forecasts for these two segments, as well as for the overall pharmaceutical industry in Poland to 2014, this document supplies data on the market share occupied by these two drug categories in terms of value and volume, and prices of innovative drugs and generics in Poland and as compared to other markets. It simplifies complex issues such as the Polish reimbursement process, upcoming changes to reimbursement and the lists of reimbursed and non-reimbursed drugs, fixed outlays of the National Health fund, payment structures and operations of … Continue reading →

Drugs cheat Nadzeya Ostapchuk has taken a swipe at Valerie Adams as she continues to deny she took steroids at the Olympics. The Belarusian, who failed two separate tests at the London games, was stripped of her shotput gold medal earlier this week. That gave defending champion Adams her second consecutive Olympic gold and secured her place as a legend of New Zealand sport. But Ostapchuk has gone on the attack and has amazingly stated that Adams was left off the start list in London due to a failed drugs test and not because of an administrative error. "She was not even in starting line-up before the games, because she had a positive drug test in 2005," Ostapchuk told Belarusian media. Nick Cowan, Adams' manager, strongly denied the accusations on TV3 tonight. "She is obviously angry. She obviously has her own issues that she needs to deal with. She has been caught. "She has a right to go through the process that she wants to go through, but she doesn't have a right to make slanderous comments," he said. The latest claims come just hours after Ostapchuk said she was framed by a former coach. NZ Newswire earlier reported that: … Continue reading →

Interview by Chris Smith, words by Amy Gladwell Newsbeat reporters Please turn on JavaScript. Media requires JavaScript to play. Russell Brand: ''I took drugs every single day'' Russell Brand says he thinks drug laws should be changed and that illegal drugs should be made "freely available" through chemists. The comedian, presenter and actor says he thinks it would work better than the current system as it would be "controlled" and drug addicts could be registered. The 37-year-old claims drug-related theft would fall and it would keep more people out of prison and get them into recovery. The star has been speaking to Newsbeat ahead of a BBC television documentary airing later this week in which he shares his own battle to stay clean. He says he wants to challenge how our society deals with addiction. "I think it's an issue like no other that's being treated in a weird way," he said. "The people controlling it don't understand it at all." Read the original: Brand wants drugs to be legalised … Continue reading →

With two new prescription weight-loss drugs approved for the U.S. market and a third under consideration, an industry-sponsored panel of experts has adopted a welter of recommendations on how the new crop of medications should be used, how their risks and benefits should be assessed by physicians and regulators, and what patients should expect of them. On the last of those questions--what patients should expect of the new drugs--the expert panel urged the Food and Drug Administration to "help patients manage their expectations regarding obesity drug use." The panel noted that for those taking any of the drugs newly approved or still under consideration, weight reduction would likely plateau at 5% to 10% of body weight loss. Patients should understand that "such weight loss is not likely to produce dramatic results in physical appearance" but could result in"significant improvements in health," the panel declared. The report released Tuesday, titled "Obesity Drug Outcome Measures," reflects the consensus of a "dialogue group" convened by public health experts at George Washington University in Washington. The group and its consensus report were funded with grants from five pharmaceutical companies (among them the makers of the newly approved Qsymia and Belviq and the candidate drug … Continue reading →

Drugs cheat Nadzeya Ostapchuk has taken a swipe at Valerie Adams as she continues to deny she took steroids at the Olympics. The Belarusian, who failed two separate tests at the London games, was stripped of her shotput gold medal earlier this week. That gave defending champion Adams her second consecutive Olympic gold and secured her place as a legend of New Zealand sport. But Ostapchuk has gone on the attack and has amazingly stated that Adams was left off the start list in London due to a failed drugs test and not because of an administrative error. "She was not even in starting line-up before the games, because she had a positive drug test in 2005," Ostapchuk told Belarusian media. "When there are rumours then most likely it means Valerie had some problems. Therefore what Adams says now about me is a joke. We will see how all of this will end, including for her." Nick Cowan, Adams' manager, strongly denied the accusations on TV3 tonight. "She is obviously angry. She obviously has her own issues that she needs to deal with. She has been caught. "She has a right to go through the process that she wants to … Continue reading →

WINNIPEG, MANITOBA--(Marketwire - Aug. 13, 2012) - Miraculins Inc., (MOM.V) a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk assessment technologies for unmet clinical needs, announces today an agreement with London Drugs, one of Canada's leading pharmacy chains, and Pear Healthcare Solutions, that will see the retail pharmacy launch of its PreVu(R) Non-Invasive Skin Cholesterol Point of Care (POC) Test take place in up to ten London Drugs locations in Vancouver and the Lower Mainland, planned for October 2012. "This pilot program is a very significant milestone for PreVu in Canada, as well as a major step forward in the commercialization of the technology worldwide," said Paul Moreau, Vice President, Sales and Marketing for Miraculins Inc. "We are very pleased that London Drugs, a highly respected retail brand in the healthcare services sector, wants to make the PreVu POC Test available to its customers to help them better understand their risk of coronary artery disease (CAD). With over 70,000 heart attacks in Canada each year, resulting in over 16,000 deaths, this pilot program represents an important development towards realizing better heart health for all Canadians at risk." As part of the agreement, London Drugs will … Continue reading →